483Nov 1, 2023

483 Document: Spirit Pharmaceuticals


FDANews 483 Spirit Pharmaceuticals Nov 1 2023 top
Gam S. Zamil FDA Investigator Paige R. Mccoy FDA Investigator

On Nov 01, 2023, the FDA inspected Spirit Pharmaceuticals's Ronkonkoma site. Explore the inspectional observations.